Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Amortization of Goodwill (2018)

Historic Amortization of Goodwill for Celldex Therapeutics (CLDX) over the last 1 years, with Q1 2018 value amounting to $91.0 million.

  • Celldex Therapeutics' Amortization of Goodwill changed N/A to $91.0 million in Q1 2018 from the same period last year, while for Dec 2018 it was $91.0 million, marking a year-over-year change of. This contributed to the annual value of $91.0 million for FY2018, which is N/A changed from last year.
  • Per Celldex Therapeutics' latest filing, its Amortization of Goodwill stood at $91.0 million for Q1 2018.
  • In the past 5 years, Celldex Therapeutics' Amortization of Goodwill registered a high of $91.0 million during Q1 2018, and its lowest value of $91.0 million during Q1 2018.